Suchergebnisse - (Person:"Ayati, Adileh")

PubPharm (6)

1

Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy

enthalten in: European journal of medicinal chemistry | 2021

von Ayati, A. | Moghimi, S. | Toolabi, M. | +1

2

Design, synthesis, and biological evaluation of 1-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-3-phenylurea derivatives as anticancer agents

enthalten in: Medicinal chemistry research | 2020

von Aghcheli, A. | Toolabi, M. | Ayati, A. | +7

3

Design, synthesis, and biological evaluation of 1-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-3-phenylurea derivatives as anticancer agents

enthalten in: Medicinal chemistry research | 2020

von Aghcheli, A. | Toolabi, M. | Ayati, A. | +7

4

A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy

enthalten in: Bioorganic chemistry | 2020

von Ayati, A. | Moghimi, S. | Salarinejad, S. | +3

5

Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety

enthalten in: European journal of medicinal chemistry | 2018

von Ayati, A. | Oghabi Bakhshaiesh, T. | Moghimi, S. | +6

6

Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents

enthalten in: European journal of medicinal chemistry | 2018

von Ayati, A. | Esmaeili, R. | Moghimi, S. | +6

1
[1]